Jun 08,2019

Medtronic Initiates Pivotal Trial for Bluetooth Enabled MiniMed(TM) 780G Advanced Hybrid Closed Loop System Designed to Automate Correction Bolusing

Medtronic plc, the global leader in medical technology, today announced the enrollment of the first study participants in the company's pivotal trial of its Bluetooth® enabled MiniMed(TM) 780G advanced hybrid closed loop (AHCL) system. This next-generation system is designed to automate the delivery of correction boluses when the user experiences, or is predicted to experience, prolonged high glucose levels based on their sensor readings.

#closed loop

View Analyst & Ambassador Comments
Go to original news
Jun 09,2019

Insulet’s Omnipod® Horizon™ Hybrid Closed-Loop System Improves Glycemic Control in Patients as Young as Two Years Old with Type 1 Diabetes

Insulet Corporation, the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced that positive results from the most recent clinical trial of the Omnipod® Horizon™ Automated Insulin Delivery System (Omnipod Horizon System) were presented during the American Diabetes Association (ADA) 79th Scientific Sessions in San Francisco, California. The study demonstrated that the investigational Omnipod Horizon System performed well and was safe for up to four days of use in children as young as two years old with type 1 diabetes.

CLINICAL STUDY

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Jun 09,2019

One Drop Launches 8-Hour Blood Glucose Forecasts for People with Type 2 Diabetes on Insulin

One Drop launches 8-hour blood glucose forecasts, expanding upon the company's AI-powered Automated Decision Support and making One Drop the first and only provider of blood glucose forecasts for people with type 2 diabetes.

PRODUCT

#mobile app

#dtx

View Analyst & Ambassador Comments
Go to original news
Jun 10,2019

Real-World Data from Guardian(TM) Connect and Sugar.IQ(TM) Reveal Improved Diabetes Outcomes

Medtronic plc, the global leader in medical technology, today announced real-world data on its Guardian(TM) Connect continuous glucose monitoring (CGM) system and Sugar.IQ(TM) diabetes assistant app presented at the 79th Scientific Sessions of the American Diabetes Association (ADA) Annual Meeting in San Francisco. The data found that people using the Guardian Connect system with the Sugar.IQ app experienced 4.1% more Time in Range (63.4%) compared to Guardian Connect alone (59.3%) which represents about one extra hour per day.

CLINICAL STUDY

#cgm

View Analyst & Ambassador Comments
Go to original news
Jun 11,2019

DarioHealth Reports Improvement in Glycemic Outcomes with Key Diabetes Findings at the American Diabetes Association's 79th Scientific Sessions

DarioHealth Corp., a leading global Digital Therapeutics (DTx) company with connected devices, mobile software and large data solutions presented two studies reporting new real-world results at the American Diabetes Association's (ADA) 79th Scientific Sessions in San Francisco, California. The studies present a retrospective data evaluation reviewing hundreds of Type 2 Diabetes (T2D) active Dario mobile app users.

CLINICAL STUDY

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jun 13,2019

Tandem Diabetes Care Reports Positive Results from Two Studies of the T:Slim X2 Insulin Pump with Control-IQ Technology

Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, today announced positive results from two studies of the t:slim X2™ insulin pump with Control-IQ™ advanced hybrid closed-loop technology. Data from both studies demonstrated that the system achieved the primary outcome of increasing time in range (70-180 mg/dL) without any severe hypoglycemic events.

CLINICAL STUDY

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Jun 13,2019

Springbuk And One Drop Partner To Bring Data-Driven Condition Management To Employers And Benefits Consultants

Springbuk, the nation's leading employer-facing health intelligence platform, today announced a national preferred partnership with One Drop, a leader in healthy lifestyle and condition management programs for employers. Through this partnership, the companies will enable employers to take control of their healthcare costs while at the same time empowering employees to make more informed decisions to live healthier lives.

COLLABORATION PARTNERSHIP

#institution

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jun 18,2019

Virta Health Engages with Willis Towers Watson to Accelerate Adoption of Type 2 Diabetes Reversal Treatment

Virta Health, the first company to sustainably reverse type 2 diabetes without the use of medications or surgery, announced today a new engagement with Willis Towers Watson, a leading global advisory, broking and solutions company. The collaboration accelerates adoption of the Virta Treatment among self-insured employers while addressing a critical employer need.

COLLABORATION PARTNERSHIP

#insurance

View Analyst & Ambassador Comments
Go to original news
Jun 19,2019

Teladoc Health Strategic Investment: Vida Health Raises $30 Million in Series C Funding

Vida Health, a personalized virtual care platform for physical and behavioral health, today announced the close of $30M in Series C investment. Strategic investors include GuideWell Mutual Holding Corporation, Teladoc Health and Workday Ventures.

FUNDING SERIES C
View Analyst & Ambassador Comments
Go to original news
Jun 26,2019

DayTwo, Microbiome Startup for Diabetes, Raises $31M for U.S. Growth

DayTwo has snagged $31 million as it looks to provide nutritional support to the 30 million people living with type 2 diabetes across the United States.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES